Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer

Go back to Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer
(NASDAQ: NTLA) Delayed: 13.28 +1.68 (14.48%)
Previous Close $11.60    52 Week High $30.40 
Open $12.10    52 Week Low $11.86 
Day High $13.35    P/E N/A 
Day Low $12.01    EPS $0.00 
Volume 6,112,132